Saniona’s moving day postponed due to a lack of experience
Denmark-based biotech Saniona is not allowed to move its listing to the Nasdaq Stockholm Small Cap, as the market does not believe its executive management has adequate experience. “of course it tarnishes our reputation,” says a surprised finance chief.
BY STEFAN SINGH KAILAY
“We are a bit surprised that they have reached this conclusion. But that’s how it is. It’s not the end of the world.”
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Saniona readies phase II trial in diabetes
For abonnenter
